Nicole Cabbad
Plastic Surgery · Lake Mary, FLNPI 1306133004
Payments from drug & device makers
Across 18 payments — averaging $42.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$246
- Integra Lifesciences Corporation$181
- Smith+Nephew$112
- Eagle Pharmaceuticals, Inc.$48
- Sanofi$39
- LEO Pharma Inc.$25
- plus $118 from 6 others
What the payments were for
- Food & beverage$58876%
- Other$18124%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $246 |
| Integra Lifesciences Corporation | 1 | $181 |
| Smith+Nephew | 1 | $112 |
| Eagle Pharmaceuticals, Inc. | 1 | $48 |
| Sanofi | 2 | $39 |
| LEO Pharma Inc. | 1 | $25 |
| Organogenesis Inc. | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Journey Medical Corporation | 1 | $21 |
| Incyte Corporation | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$769 in reported general payments places this provider in the 25th percentile of 456 plastic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 261 | $12,397 |
| Cephalexin | 718 | $3,690 |
| Mupirocin | 486 | $3,122 |
| Doxycycline Hyclate | 259 | $1,811 |
| Bacitracin-PolymyxinBacitracin/Polymyxin B Sulfate | 46 | $643 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 58 | $515 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Lake Mary
- Robert RehnkeSt Petersburg$6.1M
- Enrique HanaberghAventura$2.1M
- Anthony DardanoBoca Raton$586K
- Devinder SinghMiami$407K
- Brad HermanSouth Miami$293K
- Melanie Aya-AyTampa$283K
- Gloria YeeMiami$268K
- Daniel KappWest Palm Beach$252K
- Essie Kueberuwa YatesWeston$197K
- Michael MirmaneshPinellas Park$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.